Baxter Form-483 Details 147 Leak Complaints at Drug Plant

Share

FDA has released the Form 483 underlying its September 29 Warning Letter to Baxter International, providing additional details about manufacturing deficiencies at the company's Round Lake, IL, sterile injectable drug facility, including approximately 147 complaints involving leaking drug containers since 5/2023.

The just-posted 13-page Form 483, issued following a 3/23-4/02 inspection, also documents repeated failures to detect leaking containers during visual inspection.

Investigators reported that leaking media-fill units were recovered in about 21 media-fill runs conducted since 2/7/2023. The units initially passed Baxter's 100% visual inspection process but were subsequently found leaking after incubation, sometimes exhibiting turbidity. According to the Form 483, Baxter failed to adequately evaluate the effectiveness of its visual inspection process during investigations of those failures.

Investigators also questioned the company's criteria for initiating scrap alerts involving leaking units, noting that the threshold was based on historical manufacturing performance rather than the criticality of the defect.

The findings add detail to the previously reported Warning Letter, which cited recurring cephalosporin cross-contamination, inadequate aseptic processing controls, particulate contamination and deficiencies in investigations and corrective actions.

FDA's Warning Letter also criticized Baxter's response to the inspection, saying the company had not adequately addressed systemic container-closure integrity failures or demonstrated that its corrective and preventive actions would prevent recurrence.

The agency noted that similar GMP problems had been discussed with Baxter during a 2025 regulatory meeting and identified at other company facilities.

Baxter disclosed in its third-quarter regulatory filing that FDA classified the Round Lake inspection as Official Action Indicated in June. The company said it responded to the September Warning Letter last month and was continuing corrective and preventive actions.

Read more